Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Accured Expenses: 2019-2023

Historic Change in Accured Expenses for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2023 value amounting to $2.0 million.

  • ADC Therapeutics' Change in Accured Expenses was N/A to $2.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$14.1 million, marking a year-over-year change of. This contributed to the annual value of $11.1 million for FY2024, which is 178.77% up from last year.
  • As of Q4 2023, ADC Therapeutics' Change in Accured Expenses stood at $2.0 million, which was up 478.42% from -$519,000 recorded in Q3 2023.
  • ADC Therapeutics' 5-year Change in Accured Expenses high stood at $2.0 million for Q4 2023, and its period low was -$12.3 million during Q1 2023.
  • In the last 2 years, ADC Therapeutics' Change in Accured Expenses had a median value of -$519,000 in 2023 and averaged -$2.8 million.